These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38922176)

  • 1. Botulinum Toxin and Deep Brain Stimulation in Dystonia.
    de Souza JCC; Falcone ACM; Barbosa RMG; Soares MC; Munhoz R; Farah M; Capato T; Casagrande SCB; Cordellini MF; de Castro Micheli G; Limongi JCP; Barbosa ER; Listik C; Cury RG
    Toxins (Basel); 2024 Jun; 16(6):. PubMed ID: 38922176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IncobotulinumtoxinA and Deep Brain Stimulation.
    Soh D; Fasano A
    Can J Neurol Sci; 2019 Sep; 46(5):603-606. PubMed ID: 31196241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.
    Bohn E; Goren K; Switzer L; Falck-Ytter Y; Fehlings D
    Dev Med Child Neurol; 2021 Sep; 63(9):1038-1050. PubMed ID: 33772789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation for dystonia.
    Rodrigues FB; Duarte GS; Prescott D; Ferreira J; Costa J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012405. PubMed ID: 30629283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia.
    Spiegel LL; Ostrem JL; Bledsoe IO
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32429600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFNS guidelines on diagnosis and treatment of primary dystonias.
    Albanese A; Asmus F; Bhatia KP; Elia AE; Elibol B; Filippini G; Gasser T; Krauss JK; Nardocci N; Newton A; Valls-Solé J
    Eur J Neurol; 2011 Jan; 18(1):5-18. PubMed ID: 20482602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
    Ramirez-Castaneda J; Jankovic J
    Toxicon; 2014 Nov; 90():344-8. PubMed ID: 25130293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia.
    Maezawa H; Hirata M; Yoshida K
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of botulinum toxin injections in dystonia.
    Ramirez-Castaneda J; Jankovic J
    Toxins (Basel); 2013 Feb; 5(2):249-66. PubMed ID: 23381141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation.
    Gorodetsky C; Azevedo P; Candeias da Silva C; Fasano A
    Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.
    Kongsaengdao S; Arayawithchanont A; Samintharapanya K; Rojanapitayakorn P; Maneeton B; Maneeton N
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: A case series and a pilot study.
    Gupta AD; Visvanathan R
    J Rehabil Med; 2016 Jun; 48(6):559-62. PubMed ID: 27122065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of focal dystonia with botulinum toxin].
    Nagamine T; Kaji R; Hamano T; Kimura J
    Rinsho Shinkeigaku; 1991 Jan; 31(1):32-7. PubMed ID: 2044303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
    Moll M; Rosenthal D; Hefter H
    Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study.
    Teuschl Y; Bancher C; Brainin M; Dachenhausen A; Matz K; Pinter MM
    J Neural Transm (Vienna); 2022 Jan; 129(1):49-53. PubMed ID: 34689260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.